Literature DB >> 10569528

Management of ureteral obstruction secondary to pelvic malignancies.

M I Feng1, G C Bellman, C E Shapiro.   

Abstract

PURPOSE: To assess the efficacy of urinary diversion (internal v external) in the management of ureteral obstruction secondary to pelvic malignancies and the patients' quality of life after diversion. PATIENTS AND METHODS: Thirty-seven patients presented with malignant ureteral obstruction secondary to primary neoplasms of the pelvis or metastatic disease of the pelvis and retroperitoneum and underwent urinary diversion. Patients were categorized into two groups according to the success (Group I) or failure (Group II) of internal stent drainage. Successful drainage was defined according to either radiologic study or the serum creatinine concentration in the case of a solitary kidney. "Useful life" was defined as satisfying four criteria: (1) little or no pain; (2) no complications; (3) ability to return home for at least 2 months; and (4) full mental capacity.
RESULTS: Of the total patient population, 58% ultimately failed internal diversion. Nearly all (92%) of the cervical cancer patients required external drainage. Complications were seen in 10% of the stented patients and 13% of the patients with a percutaneous nephrostomy tube, but no procedure-related deaths occurred. Useful life was achieved by 84% of all patients.
CONCLUSION: Antegrade drainage should be considered initially in patients who are likely to fail internal drainage (i.e., those with cervical cancer). The majority of these patients have a reasonably good quality of life, and intervention is most often warranted.

Entities:  

Mesh:

Year:  1999        PMID: 10569528     DOI: 10.1089/end.1999.13.521

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

Review 1.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

2.  Role of Preoperative Ureteric Stenting in Optimization of Patients with Retroperitoneal Tumors Associated with Obstructive Uropathy.

Authors:  Sunirmal Choudhury; Papiya Biswas; Sayak Roy; Bitan Chatterjee; Makhan Lal Saha
Journal:  Indian J Surg Oncol       Date:  2020-11-18

3.  [Duplex ureteral stenting for intrinsic and extrinsic ureteral strictures: an effective and elegant alternative].

Authors:  F-C von Rundstedt; D Lazica; A S Brandt; M Rathert; S Roth
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

4.  Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.

Authors:  Kao-Lang Liu; Bo-Ching Lee; Jian-De Ye; Yu-Hsuan Chang; Chin-Chen Chang; Kuo-How Huang; Yuan-Ju Lee; Yeun-Chung Chang
Journal:  Eur Radiol       Date:  2018-07-04       Impact factor: 5.315

Review 5.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

6.  The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.

Authors:  C Patel; D Loughran; R Jones; M Abdulmajed; I Shergill
Journal:  BMC Urol       Date:  2017-03-10       Impact factor: 2.264

7.  Antegrade insertion of a double J catheter in the treatment of malignant ureteral obstruction: a retrospective analysis of the results obtained with a modified technique at a university hospital.

Authors:  Rômulo Florêncio Tristão Santos; Tiago Kojun Tibana; Edson Marchiori; Thiago Franchi Nunes
Journal:  Radiol Bras       Date:  2020 May-Jun

8.  Updates on the use of ureteral stents: focus on the Resonance(®) stent.

Authors:  Manoj V Rao; Anthony J Polcari; Thomas Mt Turk
Journal:  Med Devices (Auckl)       Date:  2010-12-22

9.  The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.

Authors:  Jun Miyazaki; Mizuki Onozawa; Satoshi Takahashi; Yuka Maekawa; Mitsuru Yasuda; Koichiro Wada; Yuji Maeda; Takuro Masaki; Akito Yamaguchi; Masahiko Suzuki; Yasuyuki Sakai; Tomokazu Kimura; Manabu Takai; Kensaku Seike; Takahiko Hashimoto; Shingo Yamamoto
Journal:  BMC Urol       Date:  2019-12-27       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.